FDA Drug Application (022433) for BRILINTA by ASTRAZENECA LP

Back to FDA Applications sponsored by ASTRAZENECA LP

Application Number022433
Product Number001
FormTABLET;ORAL
Dosage90MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameBRILINTA
Active IngredientTICAGRELOR



Back to FDA Applications sponsored by ASTRAZENECA LP